PDT Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.15M Sell
54,365
-41,691
-43% -$1.65M 0.12% 284
2025
Q1
$2.9M Buy
96,056
+67,062
+231% +$2.02M 0.21% 171
2024
Q4
$1.01M Buy
28,994
+15,594
+116% +$545K 0.09% 335
2024
Q3
$537K Sell
13,400
-30
-0.2% -$1.2K 0.05% 490
2024
Q2
$640K Buy
+13,430
New +$640K 0.06% 422
2023
Q4
Sell
-19,537
Closed -$886K 600
2023
Q3
$886K Buy
19,537
+1,039
+6% +$47.1K 0.11% 313
2023
Q2
$759K Buy
+18,498
New +$759K 0.1% 310
2022
Q3
Sell
-59,865
Closed -$2.22M 954
2022
Q2
$2.22M Sell
59,865
-20,205
-25% -$748K 0.2% 149
2022
Q1
$2.97M Buy
80,070
+12,373
+18% +$458K 0.26% 97
2021
Q4
$2.06M Buy
+67,697
New +$2.06M 0.16% 228
2021
Q3
Sell
-141,925
Closed -$5.66M 835
2021
Q2
$5.66M Buy
+141,925
New +$5.66M 0.37% 40
2021
Q1
Sell
-112,045
Closed -$6.34M 825
2020
Q4
$6.34M Sell
112,045
-9,537
-8% -$539K 0.43% 43
2020
Q3
$5.77M Buy
121,582
+5,282
+5% +$251K 0.38% 104
2020
Q2
$6.86M Buy
+116,300
New +$6.86M 0.47% 76
2019
Q2
Sell
-341,800
Closed -$27.7M 434
2019
Q1
$27.7M Sell
341,800
-49,500
-13% -$4.02M 1.57% 7
2018
Q4
$21.2M Sell
391,300
-37
-0% -$2K 1.18% 13
2018
Q3
$20.2M Buy
391,337
+37
+0% +$1.91K 0.84% 29
2018
Q2
$16.3M Buy
391,300
+30,100
+8% +$1.25M 0.62% 44
2018
Q1
$15.9M Sell
361,200
-45,161
-11% -$1.99M 0.54% 52
2017
Q4
$20.4M Sell
406,361
-18,549
-4% -$933K 0.59% 50
2017
Q3
$21.5M Buy
+424,910
New +$21.5M 0.71% 47
2015
Q4
Sell
-27,303
Closed -$1.1M 668
2015
Q3
$1.1M Sell
27,303
-84,607
-76% -$3.42M 0.02% 687
2015
Q2
$6.44M Buy
+111,910
New +$6.44M 0.17% 141
2014
Q3
Sell
-155,125
Closed -$5.34M 1437
2014
Q2
$5.34M Buy
+155,125
New +$5.34M 0.14% 174
2014
Q1
Sell
-6,084
Closed -$242K 1327
2013
Q4
$242K Sell
6,084
-71,088
-92% -$2.83M 0.03% 561
2013
Q3
$2.9M Buy
77,172
+25,316
+49% +$950K 0.08% 346
2013
Q2
$1.39M Buy
+51,856
New +$1.39M 0.03% 688